Skandinaviska Enskilda Banken (SEB)’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-62,041
Closed -$190K 902
2024
Q4
$190K Sell
62,041
-84,796
-58% -$259K ﹤0.01% 748
2024
Q3
$763K Buy
+146,837
New +$763K ﹤0.01% 691